Advanced search
Publication Cover
Postgraduate Medicine Volume 124, 2012 - Issue 1
Submit an article Journal homepage
60
Views
3
CrossRef citations to date
0
Altmetric
Clinical Features

Life with Hereditary Angioedema: Then and Now

Charles Joseph Lane Allergy Partners of Lynchburg, Lynchburg, VACorrespondence[email protected]
, MD,
J. Andrew Grant Professor, Departments of Medicine and Microbiology/Immunology; Program Director, Allergy and Immunology Division, University of Texas Medical Branch, Galveston, TX
, MD &
Dane Dougherty III Department of Medicine, University of Texas Medical Branch, Galveston, TX
, MS
Pages 144-151 | Published online: 13 Mar 2015

References

  • . Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31(5):407–414
  • . American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596–615
  • . Davis AE 3rd. C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol. 1988;6:595–628
  • . Kaplan A. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010;126(5):918–925
  • . Zuraw B. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027–1036
  • . Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267–274
  • . Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84(5):580–593
  • . Agostoni A, Aygören–Pürsün E, Binkley KE,. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114( 3 suppl):S51–S131
  • . Lunn ML, Santos CB, Craig TJ. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? Ann Allergy Asthma Immunol. 2010;104(3):211–214
  • . Gompels MM, Lock RJ, Abinun M,. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379–394
  • . Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am. 2006;26(4):653–658
  • . Quincke H. ÜberakutesumschreibnesHautödem. MonatschrPraktDermatol. 1882;1:129–131
  • . Strübing P. Ueberacutes (angioneurotisches) Oedema. Ztschr F Klin Med. 1885;9:381–396
  • . Osler W. Hereditary angioneurotic oedema. Am J Med Sci. 1888;95(2):362–367
  • . Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase. Am J Med. 1963;35:37–44
  • . Ensor C. Some cases illustrating the Influence of hereditary angeio-neurotic oedema. Guys Hosp Rep. 1904;58:111–120
  • . Crowder JR, Crowder TR. Five generations of angioneurotic edema. Arch Int Med. 1917;20(6):840–852
  • . Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006;101:619–627
  • . Landerman NS. Hereditary angioneurotic edema, I: case reports and review of the literature. J Allergy. 1962;33:316–329
  • . Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci. 1982;284:2–9
  • . Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc. 2000;75(4):349–354
  • . Spaulding WB. Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med. 1960;53:739–745
  • . Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol. N Engl J Med. 1976;295(26):1444–1448
  • . Zuraw B, Davis A, Castaldo A. Tolerability and efficacy of attenuated anabolic androgen therapy in 731 HAE patients. Presented at: 6th European C1 INH Deficiency Workshop; May 22–24, 2009; Budapest, Hungary

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.